Literature DB >> 20576920

Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S.

Jie Hong1, Murray Resnick, Jose Behar, Li Juan Wang, Jack Wands, Ronald A DeLellis, Rhonda F Souza, Stuart J Spechler, Weibiao Cao.   

Abstract

Inactivation of tumor suppressor gene p16 may play an important role in the progression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA). Hypermethylation of p16 gene promoter is an important mechanism inactivating p16. However, the mechanisms of p16 hypermethylation in EA are not known. Therefore, we examined whether acid increases methylation of p16 gene promoter and whether NADPH oxidase NOX5-S mediates acid-induced p16 hypermethylation in a Barrett's cell line BAR-T and an EA cell line OE33. We found that NOX5-S was present in BAR-T and OE33 cells. Acid-induced increase in H(2)O(2) production and cell proliferation was significantly reduced by knockdown of NOX5-S. Exogenous H(2)O(2) remarkably increased p16 promoter methylation and cell proliferation. In addition, acid treatment significantly increased p16 promoter methylation and decreased p16 mRNA level. Knockdown of NOX5-S significantly increased p16 mRNA, inhibited acid-induced downregulation of p16 mRNA, and blocked acid-induced increase in p16 methylation and cell proliferation. Conversely, overexpression of NOX5-S significantly decreased p16 mRNA and increased p16 methylation and cell proliferation. In conclusion, NOX5-S is present in BAR-T cells and OE33 cells and mediates acid-induced H(2)O(2) production and cell proliferation. NOX5-S is also involved in acid-induced hypermethylation of p16 gene promoter and downregulation of p16 mRNA. It is possible that acid reflux present in BE patients may activate NOX5-S and increase production of reactive oxygen species, which in turn increase p16 promoter methylation, downregulate p16 expression, and increase cell proliferation, thereby contributing to the progression from BE to EA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576920      PMCID: PMC2950676          DOI: 10.1152/ajpgi.00186.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  45 in total

Review 1.  Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer?

Authors:  Ashkan Farhadi; Jeremy Fields; Ali Banan; Ali Keshavarzian
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

2.  p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.

Authors:  D J Wong; T G Paulson; L J Prevo; P C Galipeau; G Longton; P L Blount; B J Reid
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 3.  p16(MTS-1/CDKN2/INK4a) in cancer progression.

Authors:  J W Rocco; D Sidransky
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

4.  Epigenetic patterns in the progression of esophageal adenocarcinoma.

Authors:  C A Eads; R V Lord; K Wickramasinghe; T I Long; S K Kurumboor; L Bernstein; J H Peters; S R DeMeester; T R DeMeester; K A Skinner; P W Laird
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

5.  A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1.

Authors:  B Bánfi; A Maturana; S Jaconi; S Arnaudeau; T Laforge; B Sinha; E Ligeti; N Demaurex; K H Krause
Journal:  Science       Date:  2000-01-07       Impact factor: 47.728

Review 6.  Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.

Authors:  R F Souza; C P Morales; S J Spechler
Journal:  Aliment Pharmacol Ther       Date:  2001-08       Impact factor: 8.171

7.  p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.

Authors:  Yan-Song Bian; Maria-Chiara Osterheld; Charlotte Fontolliet; Fred T Bosman; Jean Benhattar
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

8.  MethyLight: a high-throughput assay to measure DNA methylation.

Authors:  C A Eads; K D Danenberg; K Kawakami; L B Saltz; C Blake; D Shibata; P V Danenberg; P W Laird
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

9.  A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes.

Authors:  B Bánfi; G Molnár; A Maturana; K Steger; B Hegedûs; N Demaurex; K H Krause
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

10.  Modes of silencing of p16 in development of esophageal squamous cell carcinoma.

Authors:  Tomoki Tokugawa; Hiroyuki Sugihara; Tohru Tani; Takanori Hattori
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

View more
  18 in total

1.  Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.

Authors:  Jie Hong; Dan Li; Jack Wands; Rhonda Souza; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

2.  Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells.

Authors:  Xiaoxu Zhou; Dan Li; Murray B Resnick; Jose Behar; Jack Wands; Weibiao Cao
Journal:  J Pharmacol Exp Ther       Date:  2011-07-12       Impact factor: 4.030

3.  Role of Rac1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells.

Authors:  Jie Hong; Murray Resnick; Jose Behar; Jack Wands; Ronald A DeLellis; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

4.  Silencing DNA methyltransferase 1 leads to the activation of the esophageal suppressor gene p16 in vitro and in vivo.

Authors:  Jian Bai; Xue Zhang; Bangqing Liu; Haiyong Wang; Zhenzong Du; Jianfei Song
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

Review 5.  Mechanisms of superoxide signaling in epigenetic processes: relation to aging and cancer.

Authors:  Igor Afanas'ev
Journal:  Aging Dis       Date:  2015-06-01       Impact factor: 6.745

6.  Silencer-of-Death Domain Mediates Acid-Induced Decrease in Cell Apoptosis in Barrett's Associated Esophageal Adenocarcinoma Cells.

Authors:  Dan Li; Jie Hong; Weibiao Cao
Journal:  J Pharmacol Exp Ther       Date:  2016-10-18       Impact factor: 4.030

Review 7.  New nucleophilic mechanisms of ros-dependent epigenetic modifications: comparison of aging and cancer.

Authors:  Igor Afanas'ev
Journal:  Aging Dis       Date:  2013-10-21       Impact factor: 6.745

Review 8.  Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?

Authors:  Leonidas Alevizos; Ilias P Gomatos; Spyridon Smparounis; Manousos M Konstadoulakis; Georgios Zografos
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

9.  Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells.

Authors:  Dan Li; Weibiao Cao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

10.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.